These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 36941745)
1. Quality of cell blocks prepared from residual pleural effusion and bronchial washing samples for immunocytochemistry. Harabajsa S; Milutin L; Breški A; Ražnjević K; Šimić V; Branica BV; Smojver-Ježek S Cytopathology; 2023 May; 34(3):264-270. PubMed ID: 36941745 [TBL] [Abstract][Full Text] [Related]
2. Malignant pleural effusion cell blocks are reliable resources for PD-L1 analysis in advanced lung adenocarcinomas: a concordance study with matched histologic samples. Mahajan S; Nambirajan A; Gupta I; Gupta N; Gupta P; Jain D J Am Soc Cytopathol; 2022; 11(5):253-263. PubMed ID: 35589508 [TBL] [Abstract][Full Text] [Related]
3. The detection of PD-L1 expression on liquid-based cytology in pleural effusion of lung adenocarcinoma and its prognostic evaluation: Between paired liquid-based cytology and cell block samples. Ma H; Jia J; Sun Z; Xiao X; Liang S; Zhao L; Zhang Z Diagn Cytopathol; 2024 May; 52(5):235-242. PubMed ID: 38263766 [TBL] [Abstract][Full Text] [Related]
4. PD-L1 lineage-specific quantification in malignant pleural effusions of lung adenocarcinoma by flow cytometry. Yoon JY; Nayyar R; Quest G; Pabedinskas D; Pal P; Tsao MS; Schwock J; Ko HM Lung Cancer; 2020 Oct; 148():55-61. PubMed ID: 32799091 [TBL] [Abstract][Full Text] [Related]
5. Cytology cell blocks from malignant pleural effusion are good candidates for PD-L1 detection in advanced NSCLC compared with matched histology samples. Zou Y; Xu L; Tang Q; You Q; Wang X; Ding W; Zhao J; Ren G BMC Cancer; 2020 Apr; 20(1):344. PubMed ID: 32321471 [TBL] [Abstract][Full Text] [Related]
6. Refined Diagnosis of Pleural Effusions by Immunocytochemistry of Cell Blocks. Koyi H; Wilander E Anticancer Res; 2023 Feb; 43(2):669-673. PubMed ID: 36697096 [TBL] [Abstract][Full Text] [Related]
7. [Correlation between the Expression of PD-L1 in Pleural Effusion of Lung Adenocarcinoma and the Clinicopathological Features and Molecular Changes]. Ma H; Jia J; Guo H; Zhao H; Wang C; Zhao L; Sun Y; Li W; Zhang Z Zhongguo Fei Ai Za Zhi; 2020 Mar; 23(3):150-155. PubMed ID: 32209183 [TBL] [Abstract][Full Text] [Related]
8. Correlation between Classic Driver Oncogene Mutations in EGFR, ALK, or ROS1 and 22C3-PD-L1 ≥50% Expression in Lung Adenocarcinoma. Rangachari D; VanderLaan PA; Shea M; Le X; Huberman MS; Kobayashi SS; Costa DB J Thorac Oncol; 2017 May; 12(5):878-883. PubMed ID: 28104537 [TBL] [Abstract][Full Text] [Related]
9. Effects of the Storage Solution Type and Prolonged Storage on the Immunoreactivity of Cells. Ikeda K; Sato S; Chigira H; Shibuki Y; Hiraoka N Acta Cytol; 2020; 64(4):352-359. PubMed ID: 31597129 [TBL] [Abstract][Full Text] [Related]
10. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma]. Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085 [TBL] [Abstract][Full Text] [Related]
11. The application and diagnostic utility of immunocytochemistry on direct smears in the diagnosis of pulmonary adenocarcinoma and squamous cell carcinoma. Roh MH; Schmidt L; Placido J; Farmen S; Fields KL; Courey AJ; Arenberg DA; Knoepp SM Diagn Cytopathol; 2012 Nov; 40(11):949-55. PubMed ID: 21500373 [TBL] [Abstract][Full Text] [Related]
12. PD-L1 detection in histology specimens and matched pleural fluid cell blocks of patients with NSCLC. Grosu HB; Arriola A; Stewart J; Ma J; Bassett R; Hernandez M; Ost D; Roy-Chowdhuri S Respirology; 2019 Dec; 24(12):1198-1203. PubMed ID: 31209954 [TBL] [Abstract][Full Text] [Related]
13. Cell transfer technique for constructing cytological microarrays for immunocytochemical analysis. Wen CH; Lin CH; Ko PL; Kuo YF; Chen YJ; Chai CY Cytopathology; 2017 Apr; 28(2):157-163. PubMed ID: 27526949 [TBL] [Abstract][Full Text] [Related]
14. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma. Ylagan LR; Zhai J Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333 [TBL] [Abstract][Full Text] [Related]
15. Determination of PD-L1 expression in effusions from mesothelioma by immuno-cytochemical staining. Mansour MSI; Seidal T; Mager U; Baigi A; Dobra K; Dejmek A Cancer Cytopathol; 2017 Dec; 125(12):908-917. PubMed ID: 28922567 [TBL] [Abstract][Full Text] [Related]
16. Programmed death ligand 1 testing in non-small cell lung carcinoma cytology cell block and aspirate smear preparations. Noll B; Wang WL; Gong Y; Zhao J; Kalhor N; Prieto V; Staerkel G; Roy-Chowdhuri S Cancer Cytopathol; 2018 May; 126(5):342-352. PubMed ID: 29499101 [TBL] [Abstract][Full Text] [Related]
17. Use of the 22C3 anti-programmed death-ligand 1 antibody to determine programmed death-ligand 1 expression in cytology samples obtained from non-small cell lung cancer patients. Ilie M; Juco J; Huang L; Hofman V; Khambata-Ford S; Hofman P Cancer Cytopathol; 2018 Apr; 126(4):264-274. PubMed ID: 29411536 [TBL] [Abstract][Full Text] [Related]
18. Role of cytoblock on pleural effusion for diagnosis of malignant disease. Shahini L; Hoxha M; Marku F; Morina B; Cena V; Kabashi K; Mustafa L Diagn Cytopathol; 2023 Nov; 51(11):684-688. PubMed ID: 37547992 [TBL] [Abstract][Full Text] [Related]
19. Examination of cytological smears and cell blocks of pleural fluid: Complementary diagnostic value for malignant effusions. Porcel JM; Quirós M; Gatius S; Bielsa S Rev Clin Esp (Barc); 2017 Apr; 217(3):144-148. PubMed ID: 28038770 [TBL] [Abstract][Full Text] [Related]
20. Utility of cell block to detect malignancy in fluid cytology: Adjunct or necessity? Dey S; Nag D; Nandi A; Bandyopadhyay R J Cancer Res Ther; 2017; 13(3):425-429. PubMed ID: 28862203 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]